ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our goal is to create a healthier world with bold action and the power of ...

ProPhase Labs announced plans to launch DNA Complete ... The company aims to reduce overhead costs by $6 million, which could result in an $11 million positive cash flow swing.

ProPhase Labs, Inc. announced that CEO Ted Karkus will present at the upcoming Investor Summit Virtual on March 11, 2025, at 1:30 P.M. ET, offering investors insights into the company's operations ...

Try Now>> See today’s best-performing stocks on TipRanks >> Read More on PRPH: Disclaimer & Disclosure Report an Issue ProPhase Labs NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Ted Karkus, CEO of ProPhase Labs, will present to shareholders today, March 31, 2025, at 11:00 a.m. EST during the live Virtual Non-Deal Roadshow Series. The details are available below.

ProPhase Labs stock opened at $0.38 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.33 and a current ratio of 1.47. The firm has a market cap of $9.09 million, a P/E ...

GARDEN CITY, NY, March 07, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ ... at this year’s Investor Summit Virtual on March 11 th. Event: Q1 Investor Summit Presentation Time: 1:30 ...

This quarter's event is focused on MicroCap companies who are undervalued and have a catalyst. ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer ...